New Triple-Threat attack on aggressive breast cancer
NCT ID NCT03202316
Summary
This study is testing whether a combination of three drugs works better to control an aggressive form of breast cancer that has spread or returned. The drugs work together: one boosts the immune system, one blocks cancer cell growth signals, and one is a chemotherapy. The trial is for patients whose inflammatory breast cancer has progressed after standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT BREAST INFLAMMATORY CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.